Yang Xu
Yang Xu, director, Medical Affairs, Respiratory and Immunology, AstraZeneca UK
HSJ PartnersTransforming asthma care in the UK: A path forward
The SENTINEL Project transforms care, reducing SABA inhaler dependency whilst improving patient outcomes and cutting environmental impact across the UK
HSJ PartnersThe dawn of a new era in COPD care – Is this an opportunity for Integrated Care Systems to prioritise COPD and lead the way towards better health outcomes?
Yang Xu, Head of Medical, Respiratory at AstraZeneca UK, highlights the need for ICS leaders to look for opportunities to take a proactive approach to preventing COPD exacerbations